Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-dependent Anemia Due to Very Low-, Low- and Intermediate-risk (IPSS-R) Myelodysplastic Syndrome with Ring Sideroblasts: a Retrospective Multicenter Study by FISiM-ETS

NCT05520749 is registered in ClinicalTrials.gov with Fondazione Italiana Sindromi Mielodisplastiche-ETS as lead sponsor.

NCT NCT05520749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-dependent Anemia Due to Very Low-, Low- and Intermediate-risk (IPSS-R) Myelodysplastic Syndrome with Ring Sideroblasts: a Retrospective Multicenter Study by FISiM-ETS
Lead sponsor
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
January 31, 2023
Enrollment
215 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myeloid dysplasia